| Q41058932 | A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge |
| Q41276058 | An Effective Immunization of Experimental Monkeys Against a Human Malaria Parasite, Plasmodium falciparum |
| Q34530938 | Antibody and B cell responses to Plasmodium sporozoites |
| Q41825623 | Class II-restricted protective immunity induced by malaria sporozoites |
| Q43189408 | Commentary on: Antibody and B Cell Responses to Plasmodium Sporozoites |
| Q37117251 | Current status of the immunology of blood and tissue protozoa |
| Q37993739 | Dendritic cells and the malaria pre-erythrocytic stage |
| Q40075785 | Development of sporozoite vaccines |
| Q41933825 | Immunity to exoerythrocytic forms of malaria. II. Passive transfer of immunity to exoerythrocytic forms |
| Q41180633 | Immunoglobulin deficient mice generated by gene targeting as models for studying the immune response |
| Q41350655 | Immunoprophylaxis of Malaria: Sporozoite-Induced Immunity |
| Q39397318 | Interactions between malaria parasites infecting the same vertebrate host |
| Q27317107 | Kinetics of mosquito-injected Plasmodium sporozoites in mice: fewer sporozoites are injected into sporozoite-immunized mice |
| Q58569727 | Malaria prevention: from immunological concepts to effective vaccines and protective antibodies |
| Q40196682 | Malaria: immunity, vaccination and immunodiagnosis |
| Q40772365 | Plasmodium berghei: Immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen |
| Q44157746 | Plasmodium berghei: Relationship between protective immunity and anti-sporozoite (CSP) antibody in mice |
| Q40772398 | Plasmodium berghei: T cell dependence of sporozoite-induced immunity in rodents |
| Q39739867 | Prospects for Immunisation Against Malaria |
| Q38665423 | Rationale for the development of an engineered sporozoite malaria vaccine |
| Q39586525 | Recent advances in applied malaria immunology |
| Q37254129 | Skin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunity |
| Q36650703 | The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the malaria parasite? |